Literature DB >> 17569153

Fecal tumor M2 pyruvate kinase is not a specific biomarker for colorectal cancer screening.

Yogesh M Shastri, Jürgen Stein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17569153      PMCID： PMC4147133          DOI： 10.3748/wjg.v13.i19.2768

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN： 1007-9327            Impact factor:   5.742


× No keyword cloud information.
  7 in total

1.  [Faecal pyruvate kinase type M2--a valid screening parameter for colorectal cancer? Preliminary results from a multicenter comparative study].

Authors:  M Naumann; B Schaum; G M Oremek; E Hanisch; W Rösch; J Mössner; W F Caspary; J Stein
Journal:  Dtsch Med Wochenschr       Date:  2004-08-20       Impact factor: 0.628

2.  Fecal pyruvate kinase (M2-PK): a new predictor for inflammation and severity of pouchitis.

Authors:  Jaroslaw Walkowiak; Tomasz Banasiewicz; Piotr Krokowicz; Rita Hansdorfer-Korzon; Michal Drews; Karl-Heinz Herzig
Journal:  Scand J Gastroenterol       Date:  2005-12       Impact factor: 2.423

3.  [Comparison of different stool tests for the detection of cancer of the colon].

Authors:  T Vogel; C Driemel; A Hauser; A Hansmann; S Lange; M Jonas; G Möslein
Journal:  Dtsch Med Wochenschr       Date:  2005-04-08       Impact factor: 0.628

4.  Prospective multicenter evaluation of fecal tumor pyruvate kinase type M2 (M2-PK) as a screening biomarker for colorectal neoplasia.

Authors:  Yogesh M Shastri; Marc Naumann; Gerhard M Oremek; Ernst Hanisch; Wolfgang Rösch; Joachim Mössner; Wolfgang F Caspary; Jürgen M Stein
Journal:  Int J Cancer       Date:  2006-12-01       Impact factor: 7.396

5.  Colorectal cancer screening by non-invasive metabolic biomarker fecal tumor M2-PK.

Authors:  Carolin Tonus; Gero Neupert; Markus Sellinger
Journal:  World J Gastroenterol       Date:  2006-11-21       Impact factor: 5.742

6.  Measurement of fecal pyruvate kinase type M2 (tumor M2-PK) concentrations in patients with gastric cancer, colorectal cancer, colorectal adenomas and controls.

Authors:  P D Hardt; M Toepler; B Ngoumou; J Rupp; H U Kloer
Journal:  Anticancer Res       Date:  2003 Mar-Apr       Impact factor: 2.480

7.  Faecal tumour M2 pyruvate kinase: a new, sensitive screening tool for colorectal cancer.

Authors:  P D Hardt; S Mazurek; M Toepler; P Schlierbach; R G Bretzel; E Eigenbrodt; H U Kloer
Journal:  Br J Cancer       Date:  2004-08-31       Impact factor: 7.640
  7 in total
  2 in total

1.  Faecal pyruvate kinase isoenzyme type M2 for colorectal cancer screening: a meta-analysis.

Authors:  Carolin Tonus; Markus Sellinger; Konrad Koss; Gero Neupert
Journal:  World J Gastroenterol       Date:  2012-08-14       Impact factor: 5.742

2.  New faecal tests for colorectal cancer screening: is tumour pyruvate kinase M2 one of the options?

Authors:  Y M Shastri; J M Stein
Journal:  Br J Cancer       Date:  2007-10-23       Impact factor: 7.640
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.